[go: up one dir, main page]

PE20091466A1 - Derivados de 4,5-dihidro-oxazol-2-il-amina - Google Patents

Derivados de 4,5-dihidro-oxazol-2-il-amina

Info

Publication number
PE20091466A1
PE20091466A1 PE2009000228A PE2009000228A PE20091466A1 PE 20091466 A1 PE20091466 A1 PE 20091466A1 PE 2009000228 A PE2009000228 A PE 2009000228A PE 2009000228 A PE2009000228 A PE 2009000228A PE 20091466 A1 PE20091466 A1 PE 20091466A1
Authority
PE
Peru
Prior art keywords
dihydro
oxazole
ilamine
biphenyl
phenyl
Prior art date
Application number
PE2009000228A
Other languages
English (en)
Inventor
Matteo Andreini
Emanuele Gabellieri
Wolfgang Guba
Guido Marconi
Robert Narquizian
Eoin Christopher Power
Massimiliano Travagli
Thomas Woltering
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Siena Biotech Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Siena Biotech Spa filed Critical Hoffmann La Roche
Publication of PE20091466A1 publication Critical patent/PE20091466A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE 4,5-DIHIDRO-OXAZOL-2-IL-AMINA DE FORMULA (I) DONDE R1 Y R1' SON CADA UNO H, HALOGENO, ALCOXI INFERIOR, ENTRE OTROS; R2 ES H, HALOGENO, CN, ALCOXI INFERIOR, ENTRE OTROS; R3 ES H, CN, ALQUILO INFERIOR, ENTRE OTROS; R4 ES H O ALQUILO INFERIOR; X ES UN ENLACE, -NH-C(O)-, -NH- O -O-CH2; Ar ES ARILO O HETEROARILO; m ES DE 0 A 2. SON COMPUESTOS PREFERIDOS: (RS)-4-(3'-CLORO-BIFENIL-3-IL)-4-(4-METOXI-FENIL)-4,5-DIHIDRO-OXAZOL-2-ILAMINA, (RS)-4-(6-FLUOR-3'-METOXI-BIFENIL-3-IL)-4-(4-METOXI-3-METIL-FENIL)-4,5-DIHIDRO-OXAZOL-2-ILAMINA, (RS)-4-(4-DIFLUORMETOXI-3-METIL-FENIL)-4-(2'-FLUOR-5'-METOXI-BIFENIL-3-IL)-4,5-DIHIDRO-OXAZOL-2-ILAMINA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ASP2 (B-SECRETASA, BACE 1 O MEMAPSINA-2) SIENDO UTILES PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER
PE2009000228A 2008-02-18 2009-02-16 Derivados de 4,5-dihidro-oxazol-2-il-amina PE20091466A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08151546 2008-02-18

Publications (1)

Publication Number Publication Date
PE20091466A1 true PE20091466A1 (es) 2009-09-24

Family

ID=40545768

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000228A PE20091466A1 (es) 2008-02-18 2009-02-16 Derivados de 4,5-dihidro-oxazol-2-il-amina

Country Status (16)

Country Link
US (1) US7989449B2 (es)
EP (1) EP2245019B1 (es)
JP (1) JP5258904B2 (es)
KR (1) KR101259240B1 (es)
CN (1) CN101952260B (es)
AR (1) AR070395A1 (es)
AU (1) AU2009216825A1 (es)
BR (1) BRPI0907563A2 (es)
CA (1) CA2712228C (es)
CL (1) CL2009000349A1 (es)
ES (1) ES2398017T3 (es)
IL (1) IL206765A0 (es)
MX (1) MX2010008347A (es)
PE (1) PE20091466A1 (es)
TW (1) TW200938537A (es)
WO (1) WO2009103626A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700603B2 (en) * 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) * 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
EP1896032B1 (en) 2005-06-14 2012-10-31 Merck Sharp & Dohme Corp. The preparation and use of compounds as protease inhibitors
EP1896478B1 (en) * 2005-06-14 2014-05-21 Merck Sharp & Dohme Corp. Aspartyl protease inhibitors
ES2537898T3 (es) 2005-10-25 2015-06-15 Shionogi & Co., Ltd. Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
AU2007258435A1 (en) 2006-06-12 2007-12-21 Schering Corporation Heterocyclic aspartyl protease inhibitors
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2689780A1 (en) 2007-04-24 2014-01-29 Shionogi & Co., Ltd. Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group
AU2009239536C1 (en) * 2008-04-22 2012-12-13 Merck Sharp & Dohme Corp. Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
EP2305672B1 (en) 2008-06-13 2019-03-27 Shionogi & Co., Ltd. SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY
US8450308B2 (en) * 2008-08-19 2013-05-28 Vitae Pharmaceuticals, Inc. Inhibitors of beta-secretase
BRPI0918449A2 (pt) * 2008-09-11 2019-09-24 Amgen Inc compostos de anel espiro-tricíclico como moduladores de beta-secretas e métodos de uso
EP2360155A4 (en) 2008-10-22 2012-06-20 Shionogi & Co 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
ES2571057T3 (es) * 2009-03-13 2016-05-23 Vitae Pharmaceuticals Inc Inhibidores de beta-secretasa
US20110065695A1 (en) * 2009-09-11 2011-03-17 Jeremy Beauchamp Use of aminodihydrothiazines for the treatment or prevention of diabetes
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
JPWO2011070781A1 (ja) 2009-12-09 2013-04-22 塩野義製薬株式会社 置換アミノチアジン誘導体
UA103272C2 (uk) 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
CN102834384A (zh) 2009-12-11 2012-12-19 盐野义制药株式会社 *嗪衍生物
JPWO2011077726A1 (ja) 2009-12-24 2013-05-02 塩野義製薬株式会社 ４−アミノ−１，３−チアジンまたはオキサジン誘導体
JP5828848B2 (ja) 2010-02-24 2015-12-09 ヴァイティー ファーマシューティカルズ，インコーポレイテッド ベータセクレターゼインヒビター
CA2791281A1 (en) 2010-03-15 2011-09-22 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators
WO2011115928A1 (en) 2010-03-15 2011-09-22 Amgen Inc. Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use
US8815881B2 (en) * 2010-08-09 2014-08-26 Hoffmann-La Roche Inc. 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
JP5816630B2 (ja) 2010-10-29 2015-11-18 塩野義製薬株式会社 ナフチリジン誘導体
WO2012057247A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
AU2012206561B2 (en) * 2011-01-13 2015-12-17 Novartis Ag Novel heterocyclic derivatives and their use in the treatment of neurological disorders
US8399459B2 (en) * 2011-02-02 2013-03-19 Hoffmann-La Roche Inc. 1,4 oxazines as BACE1 and/or BACE2 inhibitors
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
CN103608345A (zh) 2011-04-26 2014-02-26 盐野义制药株式会社 噁嗪衍生物和含有该噁嗪衍生物的bace1抑制剂
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
TWI557112B (zh) 2012-03-05 2016-11-11 百靈佳殷格翰國際股份有限公司 β－分泌酶抑制劑
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
TW201422592A (zh) 2012-08-27 2014-06-16 Boehringer Ingelheim Int β－分泌酶抑制劑
JP2015532282A (ja) 2012-09-28 2015-11-09 ヴァイティー ファーマシューティカルズ，インコーポレイテッド β−セクレターゼの阻害剤
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9540397B2 (en) * 2014-10-10 2017-01-10 Hoffmann-La Roche Inc. BACE1 inhibitors
JP6674960B2 (ja) 2015-03-20 2020-04-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｂａｃｅ１阻害剤
US20190201410A1 (en) * 2016-06-02 2019-07-04 Purdue Pharma L.P. Trace amine associated receptor 1 agonists and partial agonists for pain treatment
CN113729026A (zh) * 2021-10-09 2021-12-03 合肥巨卓农业技术开发有限公司 一种包含啶磺草胺和异丙隆的复合除草剂
TW202342013A (zh) * 2022-02-10 2023-11-01 英屬開曼群島商百濟神州有限公司 雜環化合物、其組成物及用其進行治療之方法
WO2024112544A1 (en) * 2022-11-22 2024-05-30 Albemarle Corporation Liquid weighting agents for oil-based fluids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK302185A (da) * 1984-07-05 1986-01-06 Rolland Sa A 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling
MXPA06014793A (es) * 2004-06-16 2007-02-16 Wyeth Corp Derivados de amino-5, 5-difenilimidazolona para la inhibicion de ??-secretasa.
TW200734311A (en) * 2005-11-21 2007-09-16 Astrazeneca Ab New compounds
WO2007058601A1 (en) * 2005-11-21 2007-05-24 Astrazeneca Ab Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia
CN101600700B (zh) * 2007-02-02 2013-08-21 弗·哈夫曼-拉罗切有限公司 作为taar1配体用于cns病症的新的2-氨基噁唑啉

Also Published As

Publication number Publication date
CA2712228C (en) 2013-04-16
MX2010008347A (es) 2010-11-12
IL206765A0 (en) 2010-12-30
CN101952260B (zh) 2013-02-13
AU2009216825A1 (en) 2009-08-27
EP2245019A1 (en) 2010-11-03
KR101259240B1 (ko) 2013-04-29
EP2245019B1 (en) 2012-11-14
US20090209529A1 (en) 2009-08-20
US7989449B2 (en) 2011-08-02
CA2712228A1 (en) 2009-08-27
JP5258904B2 (ja) 2013-08-07
TW200938537A (en) 2009-09-16
AR070395A1 (es) 2010-03-31
BRPI0907563A2 (pt) 2015-08-04
JP2011512378A (ja) 2011-04-21
KR20100130595A (ko) 2010-12-13
ES2398017T3 (es) 2013-03-13
CL2009000349A1 (es) 2010-02-19
CN101952260A (zh) 2011-01-19
WO2009103626A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
PE20061106A1 (es) Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida
PE20100138A1 (es) Derivados de morfolino pirimidina usados en enfermedades relacionadas en mtor quinasa y/o pi3k
PE20121500A1 (es) 2-amino-5,5-difluor-5,6-dihidro-4h-oxazinas como inhibidores de bace 1 y/o bace 2
PE20050691A1 (es) Proceso para preparar carboxamidas 2-aminotiazol-5-aromaticas como inhibidores de la cinasa
PE20121282A1 (es) Antagonistas de espiro-oxindol de mdm2
PE20090709A1 (es) Compuestos heterociclico de 5 miembros
PE20070528A1 (es) Compuestos heterociclicos como ligandos del receptor vaniloide del subtipo 1
PE20130242A1 (es) Derivados de isoxazolo-piridina
PE20121640A1 (es) Derivados de pirazina como inhibidores de bace
PE20090160A1 (es) COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
PE20141827A1 (es) Inhibidores de proteinas quinasas
PE20140171A1 (es) Pirazoles fungicidas y sus mezclas
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
PE20120403A1 (es) Aril-piridinas como inhibidoras de sintasa de aldosterona
PE20091656A1 (es) Compuestos heterociclicos como inhibidores de la cinasa raf
PE20110875A1 (es) Derivados de isoindol como inhibidores de bace
NO20063469L (no) Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
NO20063468L (no) Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
PE20120640A1 (es) Nuevos derivados de (6-oxo-1,6-dihidro-pirimidin-2-il)-amida, su preparacion y su utilizacion farmaceutica como inhibidores de fosforilacion de akt (pkb)
ATE435223T1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
PE20090876A1 (es) Nuevos derivados de 6-aril/heteroalquiloxi benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de cmet

Legal Events

Date Code Title Description
FD Application declared void or lapsed